for the Period Ended 30 November 2024
| Directors report | |
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 30 November 2024
Principal activities of the company
Directors
The director shown below has held office during the whole of the period from
1 December 2023
to
30 November 2024
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
| 2024 | 2023 | |
|---|---|---|
|
|
£ |
£ |
| Turnover: |
|
|
| Cost of sales: |
(
|
(
|
| Gross profit(or loss): |
|
|
| Administrative expenses: |
(
|
(
|
| Operating profit(or loss): |
|
|
| Profit(or loss) before tax: |
|
|
| Tax: |
(
|
(
|
| Profit(or loss) for the financial year: |
|
|
As at
| Notes | 2024 | 2023 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Current assets | |||
| Debtors: | 3 |
|
|
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 4 |
(
|
(
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Members' funds | |||
| Profit and loss account: |
|
|
|
| Total members' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 November 2024
Basis of measurement and preparation
Turnover policy
for the Period Ended 30 November 2024
| 2024 | 2023 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 30 November 2024
| 2024 | 2023 | |
|---|---|---|
| £ | £ | |
| Other debtors |
|
|
| Total |
|
for the Period Ended 30 November 2024
| 2024 | 2023 | |
|---|---|---|
| £ | £ | |
| Bank loans and overdrafts |
|
|
| Taxation and social security |
|
|
| Other creditors |
|
|
| Total |
|
|
The company runs regular seminars in different locations within UK, particularly in London where the emphasis is laid on creating awareness and providing training on “truth about drug education. The aim is to create awareness on the use of drugs, the good and bad of its usage and the impact it has on society. For the financial year ended 30 November 2024, the company did engage in a very minimal activity.
The Company's stakeholders are women from ethnic minority resident in the UK and mainly the women in London mostly from African Community. The interaction with members helps to build live around mothering and working to support family and community. Members are exposed to variety of untapped opportunities available and what they can do to improve their lives. We seek a lot of information from members by way of interaction after seminars and find out challenges be faced them. The gathering of such information helps us to know which experts to invite for seminar presentation. This is also creating a platform for most members to engaged in socialisation. Members are given the opportunities to give feedback on programmes organised since the aim of the company is to ensure the members attention is drawn to dangers involve in taking drugs and the associated impact on people’s life if abused. The continuous excitement and euphoria expressed by members are seen as bunch mark for future growth.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
27 August 2025
And signed on behalf of the board by:
Name: CHINAGORUM JULIET NKARU
Status: Director